Next |
home / stock / cyth / cyth message board
Subject | By | Source | When |
---|---|---|---|
The now | Pedro2004 | investorshub | 05/01/2023 1:32:07 PM |
$CYTH Price trading up | tradrdad45 | investorshub | 04/30/2023 12:40:36 AM |
$CYTH MomentumIts gaining | Covid19freak | investorshub | 04/27/2023 7:53:22 AM |
$CYTH MomentumIts trading | pay in cash | investorshub | 04/26/2023 6:17:37 PM |
is it bear time? Or do we go bull? | Esa | investorshub | 04/20/2023 10:15:48 PM |
MomentumIts gaining | stockdawg44 | investorshub | 04/19/2023 3:35:46 AM |
$CYTH Time for this to show some returns | CYDYWinning | investorshub | 04/18/2023 8:16:17 PM |
great news | Esa | investorshub | 04/18/2023 6:49:35 PM |
where is the squeeze? | Lazarus | investorshub | 04/11/2023 7:19:34 PM |
$CYTH where is the squeeze? | Pedro2004 | investorshub | 04/10/2023 3:18:13 PM |
$CYTH we got news | ClayTrader | investorshub | 04/08/2023 4:42:29 AM |
Good read | thee trader | investorshub | 04/06/2023 1:52:16 PM |
$CYTH The now | tradrdad45 | investorshub | 04/04/2023 4:57:46 AM |
Price has been cut in half since you | Lazarus | investorshub | 03/29/2023 7:21:09 PM |
($CYTH) $1.90 ..MC $17 mil -has Orphan drug | Covid19freak | investorshub | 01/17/2023 8:02:43 PM |
...but, but, but https://www.otcmarkets.com/filing/html?id=16164183&guid=FC | Lazarus | investorshub | 10/31/2022 9:41:57 PM |
Insiders buying and phase 3 data coming out | Esa | investorshub | 02/08/2022 1:18:27 PM |
Picked some up today. Looks quite promising at | scotsand | investorshub | 01/06/2022 5:18:35 PM |
Trappsol Cyclo | XenaLives | investorshub | 10/08/2021 3:46:21 AM |
Yup I purchased CYTHW as well. This looks | CYDYWinning | investorshub | 04/28/2021 7:14:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Cyclo Therapeutics Inc. Company Name:
CYTH Stock Symbol:
NASDAQ Market:
-1.03% G/L:
$0.70 Last:
35,265 Volume:
$0.687 Open:
$0.70 Close:
Cyclo Therapeutics Inc. Website:
Eyenovia Inc. (EYEN) is expected to report $-8 for Q4 2024 Nemaura Medical Inc. (NMRD) is expected to report for quarter end 2024-12-31 LanzaTech Global Inc. (LNZA) is expected to report $-0.16 for Q4 2024 Investcorp Credit Management BDC Inc. (ICMB) is expected to report for Q2 2025 ...
The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol ® Cyclo™ NEWARK, N.J., March 13, 2025 (GLOBE NEWSW...
2025-02-07 09:23:14 ET DENVER, Colo., Feb 07, 2025 ( 247marketnews.com )- Cyclo Therapeutics (NASDAQ: CYTH ) reportedly made significant progress in its ongoing Phase 3 TransportNPC study. The study is evaluating Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C1 (NPC1...